Lifecycle of an Imaging Biomarker

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

Lifecycle of an Imaging Biomarker: From Validation to Dissemination

Thursday, Dec. 2, 10:30 AM - 12:00 PM

Speakers are sharing perspectives on the use of quantitative imaging as a biomarker in clinical trials and providing examples of best practices.

The speakers are:

  • Jeffrey T. Yap, PhD, senior diagnostic physicist, Dana-Farber Cancer Institute in Boston;
  • Neil M. Rofsky, MD, chief, MRI, Beth Israel Deaconess Medical Center in Boston;
  • Simon K. Warfield, PhD, director, computational radiology laboratory, Children’s Hospital in Boston.